Iovance Biotherapeutics (IOVA) Earnings Date, Estimates & Call Transcripts $7.82 +0.01 (+0.13%) (As of 10:45 AM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Iovance Biotherapeutics Latest Earnings SummaryActual EPS (Nov. 7) -$0.28 Beat By $0.03 Consensus EPS (Nov. 7) -$0.31 Iovance Biotherapeutics released Q3 2024 earnings on November 7, 2024, reporting an EPS of -$0.28, which beat analysts' consensus estimates of -$0.31 by $0.03. Quarterly revenue was reported to be $58.56 million, above analyst estimates of $53.54 million. With a trailing EPS of -$1.49, Iovance Biotherapeutics' earnings are expected to grow next year, from ($1.23) to ($0.85) per share. Conference CallConference Call TranscriptPowered by Get Iovance Biotherapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Iovance Biotherapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataIOVA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IOVA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Iovance Biotherapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243-$0.47-$0.38-$0.43Q2 20243-$0.46-$0.32-$0.39Q3 20243-$0.35-$0.32-$0.33Q4 20243-$0.28-$0.24-$0.27FY 202412-$1.56-$1.26-$1.42Q1 20251-$0.22-$0.22-$0.22Q2 20251-$0.22-$0.22-$0.22Q3 20251-$0.22-$0.22-$0.22Q4 20251-$0.21-$0.21-$0.21FY 20254-$0.87-$0.87-$0.87Q1 20261-$0.17-$0.17-$0.17Q2 20261-$0.15-$0.15-$0.15 Iovance Biotherapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/7/2024Q3 2024-$0.31-$0.28+$0.03-$0.28$53.54M$58.56M8/8/2024Q2 2024-$0.35-$0.34+$0.01-$0.34$24.59M$31.11M5/9/2024Q1 2024-$0.45-$0.42+$0.03-$0.42$1.99M$0.72M2/28/2024Q4 2023-$0.44-$0.45 -$0.01-$0.45$1.44M$0.48M11/7/2023Q3 2023-$0.46-$0.46--$0.46$4.50M$0.47M8/8/2023Q2 2023-$0.81-$0.47+$0.34-$0.47$3.91M$0.24M Get the Latest News and Ratings for IOVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Iovance Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/9/2023Q1 2023-$0.84-$0.50+$0.34-$0.50--2/28/2023Q4 2022-$0.64-$0.64--$0.64-- Iovance Biotherapeutics Earnings - Frequently Asked Questions When did Iovance Biotherapeutics announce their last quarterly earnings? Iovance Biotherapeutics (NASDAQ:IOVA) last announced its quarterly earning data on Thursday, November 7, 2024. Learn more on IOVA's earnings history. What guidance has Iovance Biotherapeutics issued on next quarter's earnings? Iovance Biotherapeutics updated its FY 2024 earnings guidance on Thursday, November, 7th. The company issued revenue guidance of $160.0 million-$165.0 million, compared to the consensus revenue estimate of $162.8 million. Did Iovance Biotherapeutics beat their earnings estimates last quarter? In the previous quarter, Iovance Biotherapeutics (NASDAQ:IOVA) reported ($0.28) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.31) by $0.03. Learn more on analysts' earnings estimate vs. IOVA's actual earnings. How can I listen to Iovance Biotherapeutics's earnings conference call? The conference call for Iovance Biotherapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Iovance Biotherapeutics's conference call transcript? The conference call transcript for Iovance Biotherapeutics's latest earnings report can be read online. Read Transcript How much revenue does Iovance Biotherapeutics generate each year? Iovance Biotherapeutics (NASDAQ:IOVA) has a recorded annual revenue of $90.86 million. How much profit does Iovance Biotherapeutics generate each year? Iovance Biotherapeutics (NASDAQ:IOVA) has a recorded net income of -$444.04 million. IOVA has generated -$1.49 earnings per share over the last four quarters. What is Iovance Biotherapeutics's EPS forecast for next year? Iovance Biotherapeutics's earnings are expected to grow from ($1.23) per share to ($0.85) per share in the next year. More Earnings Resources from MarketBeat Related Companies ITCI Earnings Date ROIV Earnings Date ASND Earnings Date RVMD Earnings Date LNTH Earnings Date LEGN Earnings Date NUVL Earnings Date BPMC Earnings Date ELAN Earnings Date CYTK Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings Why I'm telling friends to avoid gold stocks (Ad)Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. This page (NASDAQ:IOVA) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iovance Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Iovance Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IOVA Stock Alerts